The CDD works in collaboration with the Cancer Center at Boston Medical Center to offer patients with gastrointestinal cancers comprehensive, compassionate cancer care. For upper gastrointestinal malignancies, multidisciplinary cancer management is especially important. Our team includes experts in radiology, gastroenterology and surgery. Clinicians in oncologic and gastrointestinal surgery, radiation oncology and medical oncology provide cancer therapy, and access to local and national clinical trials. We also offer novel treatments such as intraluminal stents and radiofrequency ablation of liver tumors.
The CDD is widely known for our expertise in colorectal cancer screening, diagnosis and treatment. Our screening programs for people at risk of developing colorectal cancer integrate endoscopic strategies with radiological techniques such as virtual colonoscopy. Genetic counseling is also available for those at risk for developing hereditary non-polyposis colorectal cancer and familial adenomatous polyposis. The CDD has extensive experience performing endoscopic polypectomy, using both standard and advanced techniques such as argon plasma coagulation (APC) and laser ablation.
Research is currently being conducted on the application of molecular genetics to the development of new screening strategies for colorectal cancer. Studies are also being done on the development, implementation and evaluation of model programs for community-based colorectal cancer control.
Our Gastrointestinal Malignancies Practice Provides Comprehensive, Expert Care for Patients With These Cancers:
- Colon, rectum and anus
- Gallbladder and bite ducts
Diagnostic and Treatment Options
- Upper gastrointestinal endoscopy
- Endoscopic ultrasound
- Colonoscopy and sigmoidoscopy (diagnostic and screening)
- Laparoscopic colon surgery
- Sphincter-preserving surgery for rectal cancer
- Neoadjuvant and postoperative chemotherapy and radiation therapy
- Intraluminal stents
- Radiofrequency ablation of liver tumors
- Hepatic resection